Explant surgery
- Medical Review: Sameer A. Patel, MD, FACS
Explant surgery permanently removes silicone or saline breast implants. Explant surgery may also remove some or all of the scar tissue that has formed around the implant(s).
People decide to have explant surgery after breast implant reconstruction for a few reasons, such as:
- Pain and discomfort
- Problems with implants, such as hardening or leaking
- Symptoms such as fatigue, rash, brain fog, and joint pain, which have been linked to breast implants in some women
Explant surgery is different from implant exchange surgery, which replaces old implants with new ones. Women who have implant reconstruction may need to have their implants replaced after about 10–15 years, but sometimes implants last longer than that.
People choose explant surgery because they no longer want their implants. They either replace them with tissue reconstruction (also called flap reconstruction) or go flat.
Why explant surgery is done
Women often choose explant surgery because of ongoing problems with their implants. Others have developed rare but serious health problems linked to implants. Or, women may have concerns about the possible risks of breast implants over the long term and decide to have them removed.
The most common reasons for explant surgery include:
- Capsular contracture: After a breast implant is placed, the body forms a capsule of scar tissue around it. Sometimes, this capsule can harden, leading to pain and distortion.
- Implant rupture or leak: Over time, implants can weaken and leak fluid. An injury to the chest area can sometimes cause a rupture.
- Implant shifting position: Implants can shift out of place over time, causing the breasts to look out of balance.
- Range of motion problems: Some people experience tightness and discomfort in the chest, shoulder, and/or back after having implants. This limits their ability to move freely.
- Infection: Sometimes, bacteria can grow in the scar capsule around the implant. This can lead to frequent infections.
- Other problems:
- Some people experience dynamic distortion (also called animation deformity). This means that the implant looks out of place or rippled when you flex your chest muscles.
- Another issue is implant extrusion, which means that the implant pushes through the layer of skin covering it.
Although revision surgery can correct many of these problems, some women choose explant surgery instead. Others decide to have their implants removed if revision surgery doesn't solve the problem.
Less common reasons for explant surgery include:
- Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)
- Breast implant illness (BII)
- Other non-breast cancers
- Certain autoimmune conditions
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)
BIA-ALCL is a rare form of lymphoma, or immune system cancer. It has developed in a small number of women with textured breast implants.
The FDA reports that most cases of BIA-ALCL have occurred in people who had BIOCELL textured implants made by Allergan.
- In 2019, Allergan voluntarily recalled these implants as well as some tissue expanders (temporary, inflatable implants that stretch the skin before a final implant is placed).
- If you have this type of implant, the FDA does not recommend explant surgery unless you are having symptoms.
BIA-ALCL forms in the fluid and capsule that surrounds the implant. It usually grows slowly. Over time, though, it can move into the chest wall or the lymph nodes near the breast. It also can spread to other parts of the body.
BIA-ALCL symptoms can include:
- Swelling, enlargement, or hardening of the breast
- Breast shape changes
- Lumps and/or pain in the breast or armpit
- Skin rash or redness near or on the breast (less common)
BIA-ALCL can develop 1 year or many years after having breast reconstruction with textured implants. On average, though, symptoms appear 8-10 years after implants are placed.
BIA-ALCL is diagnosed using a combination of tests:
- Medical imaging, such as ultrasound and MRI
- A needle biopsy that removes fluid and/or tissue
- Lab testing on any samples taken
People who develop BIA-ALCL need to have explant surgery right away to remove the breast implant(s) and the entire capsule of scar tissue. Lymph nodes in the area may need to be removed, too. The goal is to prevent the cancer from moving beyond the breast area. It’s important to work with a plastic surgeon and a cancer care team who have experience with BIA-ALCL.
If you have textured implants:
- It’s important to know that BIA-ALCL is rare, and the risk is still considered low. The American Society of Plastic Surgeons reports that as of February 2025, there were about 460 suspected or known cases of BIA-ALCL in the U.S. and about 1,600 cases worldwide.
- Talk with your care team and plastic surgeon about BIA-ALCL. Some women who are concerned about the risk of BIA-ALCL, even with no symptoms, have chosen to have explant surgery. Others may decide to have the textured implants exchanged for smooth implants.
To learn more, visit Implant reconstruction.
Breast implant illness (BII)
Breast implant illness (BII): Some women have experienced a range of difficult symptoms after having saline or silicone breast implants placed. Doctors aren’t sure why. It may be that the immune system is reacting to the breast implant material. Or, the body might react to a film of bacteria that can form over the implant (called biofilm).
Since there’s no specific test for BII, it’s usually diagnosed after your doctor rules out other causes. It’s also hard to say how many women develop it. However, more people are sharing their experiences with BII in the press, online, and through social media.
Some BII symptoms include:
- Joint and muscle pain
- Fatigue that doesn't go away
- Trouble sleeping
- Brain fog and memory issues
- Trouble breathing
- Skin problems including rash
- Stomach, intestine, and other digestive system issues
- Dry mouth, eyes, skin, and/or hair
- Anxiety and depression
- Headaches
- Hair loss
- Heart racing or changes in heartbeat
- Frequent viruses and bacterial illnesses
If you experience these or other unusual symptoms after implant reconstruction, talk to your cancer care team and your plastic surgeon. If they haven’t treated patients with BII, or they don’t take your symptoms seriously, get a second opinion.
Small studies have found that anywhere from 70–96% of people with BII report feeling better after having their implants and capsule scar tissue removed.
Other conditions possibly linked to breast implants
Researchers are studying other conditions that may be associated with breast implants. The risk is considered low. However, they have led some people to choose explant surgery. Examples include:
- Non-breast cancers that can form in the scar capsule around breast implants, such as other lymphomas (different from BIA-ALCL) and squamous cell carcinoma (SCC). Breast-implant associated SCC, or BIA-SCC, is an aggressive cancer that starts in the lining of the capsule. In March 2023, the FDA published an alert that said small numbers of lymphomas and BIA-SCC had been reported.
- Autoimmune conditions: These happen when the body’s immune system starts attacking normal, healthy tissues. Some studies have found that implants filled with silicone gel may increase the risk of autoimmune conditions. Some examples include:
- Sjögren’s syndrome, which causes dry eyes and dry mouth
- Scleroderma, which causes the skin and connective tissues to become hard and tight
- Rheumatoid arthritis, which leads to swelling and inflammation in the joints
If you had implant reconstruction and are concerned about these conditions, talk to your care team.
How explant surgery is done
There are different approaches to explant surgery. Not all plastic surgeons are experienced with these procedures. Take time to find someone who is.
A plastic surgeon qualified to perform explant surgery may be a different plastic surgeon than the one who did your implant reconstruction. The surgeon should also have experience in whatever procedure you decide to have next:
- Aesthetic flat closure, which creates a smooth, flat chest, or
- Tissue (flap) reconstruction
There are different ways to perform explant surgery. Below, we’ll share three common types of explant surgery.
En bloc capsulectomy
In en bloc capsulectomy, the surgeon removes the implant and the scar capsule in one step, with the implant still encased in the capsule. En bloc capsulectomy is strongly recommended if you:
- Have symptoms that suggest there may be bacteria, mold, or fungus growing between the implant and capsule
- Have symptoms of breast implant illness (BII) or any autoimmune condition that might be linked to implants
- Have BIA-ALCL (breast implant-associated anaplastic large cell lymphoma)
Total capsulectomy
A total capsulectomy involves removing the implant first and then removing all of the capsule in pieces. Surgeons may use this approach if they're removing implants due to pain, discomfort, or shifting, rather than illness.
They also might choose total capsulectomy if an en bloc capsulectomy isn’t possible. Sometimes, a surgeon may find that the capsule is very thin, or it is sticking to the chest wall or ribs. This makes it difficult to remove the implant and capsule together in one piece.
Partial capsulectomy
In partial capsulectomy, the surgeon removes the implant first, and then most of the capsule.
If the scar tissue is flexible and healthy, with no signs of inflammation or infection, it might be useful in supporting a tissue flap reconstruction if you choose to have one.
In other cases, the surgeon may leave some scar tissue behind if it’s stuck very firmly to the chest wall. Removing it could risk making a hole in the chest wall, which can lead to:
- Pain
- Bleeding
- Hematoma (blood that forms a pool under the skin)
- In rare cases, a collapsed lung; if this happens at all, it’s more likely if the implant was placed below muscle
If you want to have explant surgery, talk with your plastic surgeon about your reasons, including any symptoms you’re experiencing. Together you can decide which approach makes sense for you.
During explant surgery, your surgeon also will:
- Remove regenerative tissue, such as acellular dermal matrix, that may have been used to support the implant and hold it in place.
- Repair and reposition the chest muscle, if needed. If your implants were placed under the chest muscle, the surgeon may need to reattach that muscle to the chest wall.
After performing explant surgery, many surgeons take photos of the removed implant and capsule to show what type of capsulectomy you had.
Reconstruction options after explant surgery
After explant surgery, there are two main reconstruction options:
- Going flat, using a procedure called aesthetic flat closure. This removes extra skin and tissue to create a look that is as smooth and flat as possible, although the final result may be different from person to person.
- Some plastic surgeons offer fat grafting to help create a smooth look. They suction fat cells from another area of the body, process them, and inject them into the breast area. This requires a few treatments, spaced out over time.
- If you are not sure you want to go flat permanently, your surgeon may recommend leaving some extra skin that can be used in a future reconstruction.
- Tissue reconstruction, also called flap reconstruction. This uses a section of tissue and blood vessels from the belly, buttocks, thighs, or another location to recreate the breast shape.
These procedures are usually done at the same time as explant surgery. For example, if you have explant surgery because of breast implant illness (BII), immediate tissue reconstruction is generally considered to be safe.
Depending on what type of reconstruction you have, recovery can take up to several weeks.
Sometimes, a plastic surgeon may recommend waiting before having tissue reconstruction after explant surgery:
- If you were diagnosed with an infection, your surgeon may recommend allowing time for treatment and recovery.
- If you are diagnosed with BIA-ALCL (rare), you may need to delay any further reconstruction for a couple of years after treatment is finished, although this can vary. Talk with your doctor about the best timing for you.
Your plastic surgeon can help you figure out what type of reconstruction is best for you.
Capsule, tissue, and fluid testing after explant surgery
If your surgeon recommends it, testing (also called pathology testing) may be done on the capsule and any other tissue and fluid that’s removed. Testing can check for:
- Cancer cells
- Bacteria, fungi, and mold, which can be signs of infection
- Silicone and other materials that may have been absorbed from the implant
- A protein called CD30, which can be a sign of BIA-ALCL (breast implant-associated anaplastic large cell lymphoma). Sometimes, fluid testing for CD30 is done before explant surgery, based on symptoms that suggest BIA-ALCL.
Your plastic surgeon will make recommendations on whether testing is needed in your situation. If there are signs of infection, your surgeon may prescribe antibiotics to treat it.
In cases of BIA-ALCL, your surgeon should refer you to a cancer care team with experience in treating it. You may need additional tests to confirm whether lymphoma cells have moved beyond the chest area. If so, the lymphoma would require additional treatments, such as radiation therapy or chemotherapy.
Explant surgery benefits and risks
The benefits of explant surgery depend on whatever problems you were experiencing. Examples can include:
- Relief from the pain and tightness of capsular contracture (scar capsule hardening)
- Wider, more comfortable range of motion
- Not having to worry about the future risk of rupture or leaks
- Improvement in breast implant illness symptoms, which many women with BII report happens after having their implants removed
- Not needing to have more procedures to correct problems with implants
- An end to concerns about having rare but possibly serious complications in the future, such as BIA-ALCL or immune system conditions
The risks of explant surgery include:
- Seroma, a buildup of fluid under the skin
- Hematoma, a pooling of blood under the skin
- Wound healing issues if you’ve had radiation to the area in the past
- Collapsed lung (this is rare) if the scar tissue capsule was stuck to the chest wall
Your care team can help you weigh the benefits and risks of explant surgery and any additional surgeries you have next, such as flat closure or tissue reconstruction.
Paying for explant surgery
The Women’s Health and Cancer Rights Act (WHCRA) of 1998 requires health insurance plans to pay for reconstruction procedures after mastectomy. This includes any surgeries that are medically necessary to fix problems with implants.
Explant surgery generally would be covered for the following reasons:
- Rupture or leaking
- Capsular contracture
- Pain that persists over time
- Difficulty with arm movement or range of motion
- Frequent infections
- Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)
Health insurance plans may not cover the cost of explant surgery if you want to have your implants removed due to:
- Symptoms of breast implant illness (BII)
- An autoimmune condition that may be linked to breast implants
- Concerns about the risks of keeping your implants
In these cases, if you’re also having any physical problems with the implants themselves, you and your surgeon may wish to use that as the reason for explant surgery.
Your surgeon’s office should be able to help you figure out what’s covered on your insurance plan. This includes:
- The explant surgery itself
- Any testing on the tissue and fluid removed
- What surgery you have next (flat closure or tissue reconstruction)
Keep in mind that there may be out-of-pocket costs such as copays, coinsurance, and deductibles.
You also can review your plan or call your insurance company to find out what is and isn’t covered.
Visit Financial matters, health insurance, and work to learn more about paying for care.
Stay connected
Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.
- 3-dimensional radiation therapy
- 4-hydroxytamoxifen
- ablation
- abnormal
- Abraxane
- absolute risk
- AC regimen
- AC-T regimen
- AC-T-T regimen
- AC-Taxol regimen
- AC-TH regimen
- accelerated partial-breast irradiation
- action study
- acupoint
- acupressure
- acupuncture
- acupuncture needle
- acupuncture point
- acupuncture point injection
- acupuncturist
- acustimulation
- acute
- acute pain
- adenocarcinoma
- adenopathy
- adenosis
- adjunct agent
- adjunct therapy
- adjunctive therapy
- adjuvant therapy
- advance directive
- advanced practice nurse
- adverse effect
- aerobic exercise
- agent study
- aggravating factor
- aggressive
- AJCC staging system
- Alkeran
- alkylating agent
- Allegra
- allopathic medicine
- alopecia
- amifostine
- aminoglutethimide
- amitriptyline
- anabolic steroid
- analgesic
- anaplastic
- anastrozole
- ancillary test
- anemia
- anesthesia
- anesthesiologist
- angiogenesis
- angiogenesis inhibitor
- antagonist
- anthracycline
- anti-anxiety medicine
- anti-idiotype vaccine
- anti-inflammatory
- antibody-dependent cellular cytotoxicity
- antibody therapy
- anticachexia
- anticancer antibiotic
- anticancer therapy
- anticonvulsant
- antidepressant
- antiemetic
- antiestrogen
- antifolate
- antigen-presenting cell vaccine
- antihormone therapy
- antimetabolite
- antimitotic agent
- antineoplastic
- antitumor
- anxiety
- anxiolytic
- Anzemet
- APN
- apocrine gland
- apoptosis
- aprepitant
- areola
- Aromasin
- aromatase inhibitor
- aromatherapy
- arthralgia
- ascites
- aspirate
- aspiration
- assay
- asthenia
- asymptomatic
- atypia
- atypical ductal hyperplasia
- atypical hyperplasia
- atypical lobular hyperplasia
- avoidance
- axillary lymph node
- axillary lymph node dissection
- BAK gel
- balloon catheter radiation
- baseline
- behavior modification
- best practice
- BI-RADS
- Biafine cream
- bias
- bilateral
- bilateral breast cancer
- bilateral prophylactic mastectomy
- bilateral salpingo-oophorectomy
- biofeedback
- biologic
- biopsy
- biopsy specimen
- biotherapy
- bisphosphonate
- bisphosphonate-associated osteonecrosis
- blinded study
- blood-brain barrier
- blood-brain barrier disruption
- blood cell count
- blood chemistry study
- board certified oncology pharmacy specialist
- body image
- body mass index
- bolus dose
- bone density
- bone metastasis
- bone mineral density scan
- bone scan
- bone-seeking radioisotope
- brachytherapy
- brain metastasis
- BRCA1
- BRCA2
- BRCAPro
- breast carcinoma in situ
- breast-conserving surgery
- breast density
- breast duct
- breast duct endoscopy
- breast lobe
- breast lobule
- breast reconstruction
- breast self-exam
- Brief Pain Inventory
- cachexia
- CAF regimen
- calcification
- cancer vaccine
- candidiasis
- capecitabine
- carboplatin
- carcinogen
- carcinoma
- carcinoma in situ
- carcinomatous meningitis
- carcinosis
- carcinostatic
- cardiotoxicity
- caregiver
- carmustine
- case-control study
- case report
- case series
- CAT scan
- CBC
- cell
- cell-cycle regulation
- cell proliferation
- central nervous system
- central nervous system metastasis
- central nervous system prophylaxis
- central venous access catheter
- cetuximab
- cevimeline
- chaplain
- charged-particle radiation therapy
- chemoembolization
- chemoimmunotherapy
- chemoprevention
- chemoprevention study
- chemoprotective
- chemoradiation
- chemosensitivity
- chemosensitivity assay
- chemosensitizer
- chemotherapeutic agent
- chemotherapy
- chest wall
- chest X-ray
- Chinese meridian theory
- chronic
- chronic pain
- cisplatin
- Claus model
- clergy
- clinical
- clinical breast exam
- clinical practice guidelines
- clinical researcher
- clinical resistance
- clinical series
- clinical stage
- clinical staging
- clinical study
- clinical trial
- clinician
- clodronate
- CMF regimen
- cognition
- cognitive behavior therapy
- cognitive therapy
- cohort
- cohort study
- coinsurance
- combination chemotherapy
- comedo carcinoma
- comfort care
- Coming Out
- Community Advisory Board
- comorbidity
- compassionate use trial
- complementary and alternative medicine
- complementary medicine
- complete metastasectomy
- complete remission
- complete response
- complex decongestive therapy
- compliance
- complication
- compression garment
- computed tomography scan
- concomitant
- concurrent therapy
- condition
- consolidation therapy
- constitutional acupuncture
- continuum of care
- contract research organization
- contraindication
- contralateral
- contrast material
- control group
- controlled clinical trial
- controlled study
- conventional medicine
- conventional therapy
- copayments
- cope
- coping skills
- core biopsy
- core needle biopsy
- corticosteroid
- counseling
- COX inhibitor
- cryoablation
- cryopreservation
- cryosurgery
- CT scan
- cultural competency
- cumulative dose
- cumulative exposure
- cure
- cutaneous
- cutaneous breast cancer
- cyclophosphamide
- cyclosporine
- CYP2D6 inhibitor
- cystosarcoma phyllodes
- cytopenia
- cytotoxic
- cytotoxic chemotherapy
- Cytoxan
- Data and Safety Monitoring Board
- DCIS
- de novo
- debulking
- deductible
- definitive surgery
- definitive treatment
- dehydration
- denosumab
- depression
- diagnosis
- diagnostic mammogram
- diagnostic procedure
- diagnostic technique
- diagnostic trial
- diameter
- diarrhea
- diaziquone
- DIEP flap
- dietary counseling
- dietary supplement
- dietitian
- differentiation
- diffuse
- digital mammography
- diphenhydramine
- discharge
- disease progression
- disease-specific survival rate
- distant cancer
- distant metastasis
- Distant recurrence
- distress
- DNR order
- docetaxel
- dolasetron
- dose
- dose-dense chemotherapy
- dose-dependent
- dose-limiting
- dose-rate
- double-blinded
- doxorubicin
- drain
- dronabinol
- droperidol
- drug interaction
- drug resistance
- drug therapy
- drug tolerance
- duct
- ductal carcinoma
- ductal carcinoma in situ
- ductal lavage
- duloxetine
- durable power of attorney
- dysfunction
- dysgeusia
- dyspepsia
- dyspnea
- early menopause
- early-stage breast cancer
- edema
- EEG biofeedback
- efficacy
- Eklund displacement views
- electroacupuncture
- electron beam
- eligibility criteria
- Ellence
- emesis
- emetic
- endocrine
- endocrine therapy
- endpoint
- energy healing
- enteral nutrition
- epidemiology
- epirubicin
- ER+
- ER-
- ER
- ER-PR-HER2/neu-
- eribulin mesylate
- erythema
- estradiol
- estrogen
- estrogen blocker
- estrogen receptor
- estrogen receptor-negative
- estrogen receptor-positive
- estrogen receptor test
- estrogen replacement therapy
- etanidazole
- etidronate
- everolimus
- Evista
- excision
- excisional biopsy
- exemestane
- expanded access trial
- experimental
- extranodal
- false-negative test result
- false-positive test result
- familial cancer
- family medical history
- Faslodex
- fast-neutron beam radiation
- fatigue
- FDA
- febrile neutropenia
- FEC regimen
- Femara
- fertility
- fexofenadine
- fibroadenoma
- fibrocystic breast changes
- fiducial marker
- film mammography
- fine-needle aspiration biopsy
- first-degree relative
- first-line therapy
- five-year survival rate
- fluorouracil
- fluoxetine
- FNA biopsy
- focal
- Food and Drug Administration
- Fosamax
- fractionation
- fulvestrant
- functional magnetic resonance imaging
- gadolinium
- Gail model
- gallium scan
- gamma irradiation
- Gamma Knife therapy
- gamma ray
- Gelclair
- gemcitabine
- gene
- gene expression profile
- gene therapy
- general anesthesia
- generalized anxiety disorder
- generic
- genetic
- genetic counseling
- genetic marker
- genetic marker of susceptibility
- genetic predisposition
- genetic profile
- genetic susceptibility
- genetic testing
- genetic testing
- genetics
- genome
- genome-wide association study
- genomic profile
- genomic test
- genomics
- gland
- Good Clinical Practice
- goserelin
- grade
- grading
- granisetron
- gross description
- Halaven
- hazard ratio
- healing touch
- Health Insurance Portability and Accountability Act
- healthcare provider
- healthcare proxy
- healthy control
- helical computed tomography
- HER2/neu
- Herceptin
- hereditary
- hereditary mutation
- heteronormative
- high-dose chemotherapy
- high-dose radiation
- high-energy proton therapy
- high grade
- high-risk cancer
- HIPPA
- histologic examination
- histology
- historic cohort study
- historical control subject
- homeopathic medicine
- hormonal therapy
- hormone
- hormone receptor
- hormone receptor test
- hormone replacement therapy
- hormone responsive
- hormone therapy
- hospice
- hot flash
- human epidermal growth factor receptor 2
- human participant protection regulations
- hydroxydaunorubicin
- hyperalimentation
- hypercalcemia
- hyperfractionated radiation therapy
- hyperfractionation
- hyperplasia
- hypersensitivity
- hypofractionated radiation therapy
- hypofractionation
- hypoxia
- ibandronate
- ibuprofen
- idiopathic
- image-guided radiation therapy
- imaging
- imaging procedure
- immune adjuvant
- immune function
- immune response
- immune system
- immune system tolerance
- immunization
- immunoassay
- immunocompromised
- immunodeficiency
- immunohistochemistry
- immunology
- immunomodulation
- immunosuppression
- immunotherapy
- implant
- implant displacement views
- implant radiation therapy
- implantable pump
- in network
- in situ
- incidence
- incision
- incisional biopsy
- indication
- indolent
- induction therapy
- infection
- infertile
- infertility
- infiltrating breast cancer
- infiltrating ductal carcinoma
- inflammation
- inflammatory breast cancer
- informed consent
- infusion
- ingestion
- inherited
- iniparib
- injection
- inoperable
- insomnia
- Institutional Review Board
- intensification therapy
- intensity-modulated radiation therapy
- interfering thought
- internal mammary lymph nodes
- internal radiation therapy
- International Unit
- internist
- interstitial radiation therapy
- intervention
- intervention group
- intra-arterial
- intracarotid infusion
- intradermal
- intraductal breast papilloma
- intraductal carcinoma
- intrahepatic
- intrahepatic infusion
- intramuscular
- intramuscular injection
- intraoperative radiation therapy
- intraoperative ultrasound
- intratumoral
- intravasation
- intravenous
- intravenous infusion
- intravenous injection
- intrusive thought
- intrusive thoughts
- invasive breast cancer
- invasive cancer
- invasive procedure
- investigational
- investigator
- ionizing radiation
- ipsilateral
- IRB
- irradiated
- irradiation
- irreversible toxicity
- ixabepilone
- joint pain
- Karnofsky Performance Status
- laboratory test
- lapatinib
- laser
- laser surgery
- laser therapy
- lassitude
- late effects
- late-stage cancer
- latent
- laxative
- LEEP
- legal aid organization
- lesion
- lethargy
- letrozole
- leukopenia
- levels of evidence
- Lexapro
- libido
- lidocaine
- ligation
- linac
- linear accelerator
- lipoma
- lisofylline
- liver metastasis
- liver scan
- living will
- lobaplatin
- lobe
- lobectomy
- lobular carcinoma
- lobular carcinoma in situ
- lobule
- local anesthesia
- local cancer
- local therapy
- localization
- localized
- locally advanced cancer
- locally recurrent cancer
- lomustine
- loop electrosurgical excision procedure
- loop excision
- lorazepam
- low grade
- lubricant
- lumbar puncture
- lumpectomy
- lung metastasis
- luteinizing hormone-releasing hormone agonist
- lymph
- lymph gland
- lymph node
- lymph node dissection
- lymph node drainage
- lymph node mapping
- lymph vessel
- lymphadenectomy
- lymphadenopathy
- lymphangiogram
- lymphangiography
- lymphatic basin
- lymphatic fluid
- lymphatic mapping
- lymphatic system
- lymphatic vessel
- lymphedema
- lymphography
- lymphoscintigraphy
- Lyrica
- lytic lesion
- macrocalcification
- magnetic resonance imaging
- magnetic resonance perfusion imaging
- magnetic resonance spectroscopic imaging
- mainstream medicine
- maintenance therapy
- male breast cancer
- malignancy
- malignant
- malignant pleural effusion
- malnutrition
- mammary
- mammary dysplasia
- mammary gland
- mammogram
- mammography
- MammoSite
- Mammotome
- mantle field
- MAO inhibitor
- margin
- marker
- mass
- massage therapy
- mastectomy
- mastitis
- maternal
- maximum tolerated dose
- mean survival time
- measurable disease
- medial supraclavicular lymph node
- median
- median survival time
- Medicaid
- medical castration
- medical device
- medical nutrition therapy
- medical oncologist
- Medicare
- medicine
- medullary breast carcinoma
- mega-voltage linear accelerator
- megestrol
- melphalan
- meningeal metastasis
- menopause
- menorrhagia
- menstrual cycle
- menstrual period
- menstruation
- mental health
- mental health counselor
- meridian
- mesna
- meta-analysis
- metallic
- metastasectomy
- metastasis
- metastasize
- metastatic
- methotrexate
- metoclopramide
- metronomic therapy
- microcalcification
- micrometastasis
- microscopic
- milk duct
- mind/body exercise
- mindfulness relaxation
- Miraluma test
- mitigate
- modified radical mastectomy
- molecular marker
- molecular medicine
- molecular risk assessment
- molecularly targeted therapy
- monoamine oxidase inhibitor
- monoclonal antibody
- morbidity
- mortality
- MRI
- MRSI
- MTD
- mTOR
- mucositis
- multicenter study
- multicentric breast cancer
- multidisciplinary
- multidisciplinary opinion
- multidrug resistance
- multidrug resistance inhibition
- multifocal breast cancer
- music therapy
- mutation
- mutation carrier
- myalgia
- myelosuppression
- nanoparticle paclitaxel
- narcotic
- National Cancer Institute
- National Center for Complementary and Alternative Medicine
- National Institutes of Health
- natural history study
- naturopathy
- nausea
- NCCAM
- NCI
- NCI clinical trials cooperative group
- needle biopsy
- needle localization
- needle-localized biopsy
- negative axillary lymph node
- negative test result
- neoadjuvant therapy
- neoplasm
- nerve
- nerve block
- neurocognitive
- neurologic
- neuropathy
- neurotoxicity
- neurotoxin
- neutropenia
- NIH
- nipple
- nipple discharge
- nitrosourea
- NMRI
- node-negative
- node-positive
- nodule
- nonblinded
- nonconsecutive case series
- noninvasive
- nonmalignant
- nonmetastatic
- nonprescription
- nonrandomized clinical trial
- nonsteroidal anti-inflammatory drug
- nonsteroidal aromatase inhibitor
- nontoxic
- normal range
- normative
- NP
- NPO
- NSAID
- nuclear grade
- nuclear magnetic resonance imaging
- nuclear medicine scan
- nurse
- nurse practitioner
- nutrition
- nutrition therapy
- nutritional counseling
- nutritional status
- nutritional supplement
- nutritionist
- obese
- objective improvement
- objective response
- observation
- observational study
- obstruction
- off-label
- olaparib
- oncologist
- oncology
- oncology nurse
- oncology pharmacy specialist
- oncolysis
- ondansetron
- onset of action
- oophorectomy
- open biopsy
- open label study
- open resection
- operable
- opiate
- opioid
- opportunistic infection
- oral
- organ
- orthodox medicine
- osteolytic
- osteonecrosis of the jaw
- osteopenia
- osteoporosis
- OTC
- out of network
- outcome
- outpatient
- ovarian
- ovarian ablation
- ovarian cancer
- ovarian suppression
- ovary
- over-the-counter
- overall survival rate
- overdose
- overexpress
- overweight
- ovulation
- PA
- paclitaxel
- paclitaxel albumin-stabilized nanoparticle formulation
- paclitaxel-loaded polymeric micelle
- Paget disease of the nipple
- pain threshold
- palliation
- palliative care
- palliative therapy
- palmar-plantar erythrodysesthesia
- palonosetron hydrochloride
- palpable disease
- palpation
- palpitation
- pamidronate
- panic
- papillary tumor
- Paraplatin
- parenteral nutrition
- paroxetine hydrochloride
- PARP
- PARP inhibitor
- partial-breast irradiation
- partial mastectomy
- partial oophorectomy
- partial remission or partial response
- pastoral counselor
- paternal
- pathologic fracture
- pathological stage
- pathological staging
- pathologist
- pathology report
- patient advocate
- Paxil
- peau d'orange
- pedigree
- peer-review process
- peer-reviewed scientific journal
- perfusion magnetic resonance imaging
- perimenopausal
- periodic neutropenia
- perioperative
- peripheral neuropathy
- peripheral venous catheter
- personal health record
- personal medical history
- personalized medicine
- Pertuzumab
- PET scan
- pharmacist
- phase I/II trial
- phase I trial
- phase II/III trial
- phase II trial
- phase III trial
- phase IV trial
- phlebotomy
- photon beam radiation therapy
- phyllodes tumor
- physical examination
- physical therapist
- physical therapy
- physician
- physician assistant
- physiologic
- PI3 kinase inhibitor
- pilocarpine
- pilot study
- placebo
- placebo-controlled
- plastic surgeon
- plastic surgery
- population study
- positive axillary lymph node
- positive test result
- positron emission tomography scan
- post-traumatic stress disorder
- postmenopausal
- postoperative
- postremission therapy
- potentiation
- power of attorney
- PR
- PR+
- PR-
- practitioner
- preauthorization
- precancerous
- preclinical study
- predictive factor
- pregabalin
- premalignant
- premature menopause
- premenopausal
- premium
- prescription
- prevention
- preventive
- preventive mastectomy
- primary care
- primary care doctor
- primary endpoint
- primary therapy
- primary treatment
- primary tumor
- Principal investigator
- prochlorperazine
- progesterone
- progesterone receptor
- progesterone receptor-negative
- progesterone receptor-positive
- progesterone receptor test
- progestin
- prognosis
- prognostic factor
- progression
- progression-free survival
- progressive disease
- Prolia
- proliferative index
- promegapoietin
- prophylactic
- prophylactic mastectomy
- prophylactic oophorectomy
- prophylactic surgery
- prophylaxis
- prospective
- prospective cohort study
- prosthesis
- protective factor
- protein
- protein-bound paclitaxel
- protein expression
- protein expression profile
- protocol
- proton
- proton magnetic resonance spectroscopic imaging
- pruritus
- psychiatrist
- psychological
- psychologist
- psychosocial
- psychotherapy
- PTSD
- pump
- punch biopsy
- qi
- qigong
- quadrantectomy
- quality assurance
- quality of life
- radiation
- radiation brachytherapy
- radiation dermatitis
- radiation fibrosis
- radiation necrosis
- radiation nurse
- radiation oncologist
- radiation physicist
- radiation surgery
- radiation therapist
- radiation therapy
- radical lymph node dissection
- radical mastectomy
- radioactive
- radioactive drug
- radioactive seed
- radioisotope
- radiologic exam
- radiologist
- radiology
- radionuclide
- radionuclide scanning
- radiopharmaceutical
- radiosensitization
- radiosensitizer
- radiosurgery
- radiotherapy
- raloxifene
- raloxifene hydrochloride
- randomization
- randomized clinical trial
- receptor
- RECIST
- reconstructive surgeon
- reconstructive surgery
- recreational therapy
- recurrence
- recurrent cancer
- referral
- reflexology
- refractory
- refractory cancer
- regimen
- regional
- regional anesthesia
- regional cancer
- regional chemotherapy
- regional lymph node
- regional lymph node dissection
- registered dietician
- regression
- rehabilitation
- rehabilitation specialist
- relapse
- relative survival rate
- relaxation technique
- remission
- remission induction therapy
- remote brachytherapy
- research nurse
- research study
- resectable
- resected
- resection
- residual disease
- resistant cancer
- resorption
- respite care
- response rate
- retrospective cohort study
- retrospective study
- risk factor
- Rubex
- salpingo-oophorectomy
- salvage therapy
- samarium 153
- sargramostim
- scalpel
- scan
- scanner
- scintigraphy
- scintimammography
- sclerosing adenosis
- screening
- screening mammogram
- second-line therapy
- second-look surgery
- second primary cancer
- secondary cancer
- secrete
- sedative
- segmental mastectomy
- selection bias
- selective estrogen receptor modulator
- selective serotonin reuptake inhibitor
- sentinel lymph node
- sentinel lymph node biopsy
- sentinel lymph node mapping
- sepsis
- sequential AC/Taxol-Trastuzumab regimen
- sequential treatment
- SERM
- sertraline
- Serzone
- sestamibi breast imaging
- sexuality
- sibling
- side effect
- silicone
- simple mastectomy
- simulation
- Single-agent therapy
- sleep disorder
- social service
- social support
- social worker
- sodium thiosulfate
- soft tissue
- solid tumor
- somatic
- somatic mutation
- sorafenib
- specialist
- specificity
- spiculated mass
- spinal anesthesia
- spinal block
- spiral CT scan
- spirituality
- sporadic cancer
- SSRI
- stable disease
- stage
- stage 0 breast carcinoma in situ
- stage 0 disease
- stage I breast cancer
- stage IA breast cancer
- stage IB breast cancer
- stage II breast cancer
- stage II breast cancer
- stage IIA breast cancer
- stage IIB breast cancer
- stage III breast cancer
- stage III lymphedema
- stage IIIA breast cancer
- stage IIIB breast cancer
- stage IIIC breast cancer
- stage IV breast cancer
- staging
- stamina
- standard of care
- standard therapy
- statistically significant
- stent
- stereotactic biopsy
- stereotactic radiosurgery
- sterile
- sternum
- steroid
- stress
- strontium
- study agent
- subcutaneous
- subcutaneous port
- subjective improvement
- subset analysis
- supplemental nutrition
- supplementation
- support group
- supportive care
- supraclavicular lymph node
- surgeon
- surgery
- surgical biopsy
- surgical menopause
- surgical oncologist
- survival rate
- symptom
- symptom management
- symptomatic
- synergistic
- synthetic
- syringe
- systemic
- systemic chemotherapy
- systemic disease
- systemic therapy
- TAC regimen
- tai chi
- tailored intervention
- talk therapy
- tamoxifen
- targeted therapy
- taxane
- Taxol
- Taxotere
- Tc 99m sulfur colloid
- technician
- terminal disease
- therapeutic
- therapeutic touch
- therapy
- thermography
- thiethylperazine
- thiotepa
- third-line therapy
- thrush
- time to progression
- tinnitus
- tissue
- tissue flap reconstruction
- TNM staging system
- tomography
- tomotherapy
- topical
- topical chemotherapy
- topoisomerase inhibitor
- total estrogen blockade
- total mastectomy
- total nodal irradiation
- total parenteral nutrition
- toxic
- toxicity
- tracer
- traditional acupuncture
- tranquilizer
- transdermal
- transfusion
- transitional care
- translational research
- trastuzumab
- trauma
- treatment field
- trigger
- trigger point acupuncture
- triple-negative breast cancer
- tumescent mastectomy
- tumor
- tumor antigen vaccine
- tumor board review
- tumor burden
- tumor debulking
- tumor load
- tumor marker
- tumor volume
- Tykerb
- ulcer
- ulceration
- ultrasound-guided biopsy
- ultrasound/ultrasonography
- ultraviolet radiation therapy
- uncontrolled study
- undifferentiated
- unilateral
- unilateral salpingo-oophorectomy
- unresectable
- unresected
- upstaging
- urticaria
- VACB
- vaccine therapy
- vacuum-assisted biopsy or vacuum-assisted core biopsy
- Valium
- vancomycin
- vandetanib
- vascular endothelial growth factor-antisense oligonucleotide
- vascular endothelial growth factor receptor tyrosine kinase inhibitor
- vein
- Velban
- venipuncture
- venous sampling
- Versed
- vertebroplasty
- vinorelbine
- vital
- vomit
- watchful waiting
- wedge resection
- Wellcovorin
- Western medicine
- WGA study
- white blood cell
- whole cell vaccine
- whole genome association study
- wide local excision
- wire localization
- wound
- X-ray therapy
- Xanax
- Xeloda
- xerostomia
- Xgeva
- yoga
- ziconotide
- Zinecard
- Zofran
- zoledronic acid
- Zoloft
- Zometa
Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill its mission of providing trusted information and a community of support to those impacted by the disease, Living Beyond Breast Cancer offers on-demand emotional, practical, and evidence-based content. For over 30 years, the organization has remained committed to creating a culture of acceptance — where sharing the diversity of the lived experience of breast cancer fosters self-advocacy and hope. For more information, learn more about our programs and services.